HealthCor Management »

Acrivon Therapeutics shares owned by HealthCor Management

Quarter-by-quarter ownership of Acrivon Therapeutics (ACRV) shares owned by HealthCor Management from 13F filings

Historical chart of HealthCor Management investment in Acrivon Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Acrivon Therapeutics held by HealthCor Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Acrivon Therapeutics by HealthCor Management

Quarter filed Position value Share count Share price at filing
2022-12-31 $3.3M 284k 11.52

More positions owned by HealthCor Management

BioMarin Pharmaceutical (BMRN)
Dex (DXCM)
Cytokinetics Com New (CYTK)
Acrivon Therapeutics Common Stock (ACRV)
Hyperfine Com Cl A (HYPR)
Alkermes SHS (ALKS)
CONMED Corporation (CNMD)
Neurocrine Biosciences (NBIX)
Syndax Pharmaceuticals (SNDX)
Chinook Therapeutics
Intuitive Surgical Com New (ISRG)
Blueprint Medicines (BPMC)
Geron Corporation (GERN)
Penumbra (PEN)
Rocket Pharmaceuticals (RCKT)

View all positions for HealthCor Management

Top funds holding Acrivon Therapeutics

RA Capital Management
Sands Capital Ventures
Citadel Advisors
Wellington Management Company
UBS Group
Vanguard Group
Renaissance Technologies
Acorn Capital Advisors
BlackRock
Two Sigma Investments
Jane Street
Geode Capital Management
Millennium Management
Marshall Wace
Two Sigma Advisers

View all funds holding Acrivon Therapeutics